A detailed history of Rhs Financial, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Rhs Financial, LLC holds 12,891 shares of BMY stock, worth $574,165. This represents 0.31% of its overall portfolio holdings.

Number of Shares
12,891
Previous 9,917 29.99%
Holding current value
$574,165
Previous $459,000 26.58%
% of portfolio
0.31%
Previous 0.27%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 22, 2025

BUY
$43.31 - $48.98 $128,803 - $145,666
2,974 Added 29.99%
12,891 $581,000
Q2 2025

Jul 25, 2025

BUY
$44.12 - $59.6 $437,538 - $591,053
9,917 New
9,917 $459,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $94.7B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Rhs Financial, LLC Portfolio

Follow Rhs Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhs Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rhs Financial, LLC with notifications on news.